2017
DOI: 10.1016/j.expneurol.2017.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Differential effects of levodopa and apomorphine on neuronal population oscillations in the cortico-basal ganglia loop circuit in vivo in experimental parkinsonism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
8
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 62 publications
3
8
0
Order By: Relevance
“…To further confirm the beta oscillations, L-dopa, which is widely used in PD patient therapy and therapeutic studies in the PD rat model, was injected into the abdomen in the PD rat model (40 mg/kg body weight), and continuous data were recorded 40 min after injection. As shown in Figure 3c, the beta peak was removed, which demonstrated that the beta oscillation was eliminated by L-dopa, which is consistent with previous work [26,30,31].…”
Section: The Self-designed Recording Electrode Successfully Acquires supporting
confidence: 91%
“…To further confirm the beta oscillations, L-dopa, which is widely used in PD patient therapy and therapeutic studies in the PD rat model, was injected into the abdomen in the PD rat model (40 mg/kg body weight), and continuous data were recorded 40 min after injection. As shown in Figure 3c, the beta peak was removed, which demonstrated that the beta oscillation was eliminated by L-dopa, which is consistent with previous work [26,30,31].…”
Section: The Self-designed Recording Electrode Successfully Acquires supporting
confidence: 91%
“…The pharmacotherapy of PD is primarily based on two classes of drugs: dopamine precursors, (levodopa) and dopamine receptor agonists (apomorphine) and both therapies reduces the beta-band activity. However, levodopa is more effective in modulating beta-band power compared to other drugs (Kuhn et al, 2017). In MPTPtreated NHP models, abnormal oscillations in the basal-ganglia network was more prominent in the lower frequency bands (<13 Hz) compared to PD patients (Devergnas et al, 2014).…”
Section: Discussionmentioning
confidence: 93%
“…On average, LD strongly suppressed beta activity (Off LD: 4.3 ± 0.9 AUC, On LD: 2.4 ± 0.9 AUC, P < 0.001; Supplementary Figure S2B), as previously shown by us and others. 27,33 Levodopa Leads to a Progressive Increase in AIMs Thirty-one days after the 6-OHDA lesion, the animals were treated once daily with LD for 3 weeks. At days 1, 4, 10, 16, and 21, we recorded M1 ECoG as well as videotaped motor behavior.…”
Section: Levodopa Suppresses Cortical Beta Powermentioning
confidence: 99%